.gilead
Is .gilead a real TLD? Who’s applying to run it?
.gilead is not contested. One application for it is on ICANN’s Reveal Day list, as of 7 October 2026. It is Gilead Sciences.
A single-company brand extension: useful only to its owner, with no public registrations and no resale market.
the applicant company itself, for corporate microsites, campaign and product pages, and secure links it controls; no third-party buyers
The 2012 applications making the most similar bet. Chosen by AI from every string in that round, without being told what happened to any of them.
Same bet exactly: a research-driven biopharma company staking its corporate identity on a non-descriptive, meaning-free company word that only works because institutional audiences (prescribers, investors, regulators) already recognize the firm — there is no consumer category traffic to inherit.
A prescription-pharma corporate name with no retail shelf presence putting its primary identity on a short word whose everyday meaning (a flower, a given name) it must out-rank on brand equity alone — the same collision between a company name and an ordinary English word that .gilead faces.
A mid-size Rx-only pharmaceutical maker betting on its bare corporate name as its namespace, where the whole value is internal consolidation and corporate signaling rather than any demand for the string itself.
What a .gilead domain is
.gilead is not a TLD yet. It is a string on our record of the ICANN 2026 new gTLD round, filed under Brand. One application for it is on ICANN’s Reveal Day list.
Is the .gilead domain extension real yet?
.gilead is not yet a domain extension you can register: nothing resolves under it, and no registrar sells names in it. It is a string applicants have put forward in the ICANN 2026 new gTLD round, the process that decides whether it becomes one.
When can you buy a .gilead domain?
You can’t yet. ICANN publishes every applied-for string on Reveal Day, 7 October 2026 at 18:00 UTC. A .gilead name can only be registered after that, once the string is delegated and its registry opens. Last round's closest parallel to .gilead was .abbvie, delegated on 6 April 2016.
Is .gilead a real TLD?
Not yet. .gilead is not in the DNS root, so nothing resolves under it. It’s here because .gilead is on ICANN’s Reveal Day list of applied-for strings. Every entry on this page links to its source.
- Gilead Sciences · first recordedICANN
“GSHL2680T-T51995 · Gilead Sciences Holding, LLC · primary”ICANN
- The verified-facts block shows a single confirmed application by Gilead Sciences Holding, LLC with no contention and no category tag, which is the profile of a closed dot-brand TLD rather than an open namespace. Known demand: none from the public, by design; the only plausible registrant is the operator. By analogy (flagged as analogy) with corporate dot-brands from the 2012 round, outcomes split between brands that moved real customer-facing properties onto the TLD and gained a modest trust and anti-phishing signal, and brands that held the string defensively and later let it lapse; the specific split is unknown. Band chosen: 10-29 (vanity/narrow), at the bottom edge. Not the band above (30-49) because registrations at volume or on price cannot happen on a closed TLD and there is no aftermarket at all. Not the band below (1-9) because there is one real buyer with genuine primary-identity utility: a large pharmaceutical company can credibly use branded second-level names for its own trial, product, and investor pages over the next 5 years. Main market uncertainty: whether the operator actually migrates meaningful traffic to the TLD or treats it as a defensive holding, which decides whether end-use utility is real or purely nominal.